SIX Swiss Exchange · Healthcare
Invest in Siegfried stock from India
Indian and foreign residents can buy Siegfried (SFZN) shares directly through Paasa.
By Paasa · Updated
Siegfried at a glance
- Price
- CHF 72.60-CHF 1.55 (2.09%)
- Market cap
- CHF 3.18B
- Day range
- CHF 71.10 – CHF 74.60
- P/E
- 18.57
- Dividend yield
- 0.55%
- Volume
- 119.36K
- 1 month
- -1.76%
- 6 months
- -1.09%
- YTD
- -2.81%
- 1 year
- -7.16%
- 5 years
- -12.69%
Siegfried statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | CHF 1.3B | CHF 1.3B | CHF 1.3B | CHF 1.2B | CHF 1.1B |
| Gross profit | CHF 352.4M | CHF 329.1M | CHF 320.4M | CHF 318.7M | CHF 239.3M |
| Operating income | CHF 210.3M | CHF 199.3M | CHF 172.1M | CHF 227.6M | CHF 130.0M |
| Net income | CHF 168.7M | CHF 160.1M | CHF 112.8M | CHF 156.5M | CHF 95.6M |
| Earnings per share | CHF 3.85 | CHF 3.71 | CHF 26.61 | CHF 37.07 | CHF 22.73 |
| EBITDA | CHF 306.7M | CHF 289.5M | CHF 241.2M | CHF 308.3M | CHF 213.5M |
| Total assets | CHF 2.2B | CHF 1.9B | CHF 1.9B | CHF 1.8B | CHF 1.7B |
| Total debt | CHF 575.2M | CHF 490.1M | CHF 525.0M | CHF 590.0M | CHF 560.0M |
| Cash and short-term investments | CHF 103.8M | CHF 39.6M | CHF 56.6M | CHF 91.6M | CHF 73.0M |
| Shareholders' equity | CHF 1.1B | CHF 980.2M | CHF 838.2M | CHF 710.9M | CHF 608.2M |
| Operating cash flow | CHF 221.9M | CHF 168.8M | CHF 208.6M | CHF 134.5M | CHF 112.4M |
| Free cash flow | CHF 10.0M | −CHF 12.1M | CHF 71.5M | CHF 19.3M | −CHF 1.0M |
| Capital expenditure | −CHF 211.9M | −CHF 180.8M | −CHF 137.1M | −CHF 115.2M | −CHF 113.4M |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in CHF; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Ypsomed | YPSN.SW | CHF 360.40 | CHF 4.74B |
| Galenica | GALE.SW | CHF 82.55 | CHF 4.11B |
| Tecan | TECN.SW | CHF 223.20 | CHF 2.82B |
| BB Biotech | BION.SW | CHF 51.10 | CHF 2.82B |
| Medacta | MOVE.SW | CHF 114.00 | CHF 2.27B |
| SKAN | SKAN.SW | CHF 66.90 | CHF 1.50B |
| PolyPeptide | PPGN.SW | CHF 44.10 | CHF 1.46B |
| Cosmo Pharmaceuticals | COPN.SW | CHF 58.70 | CHF 1.01B |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in Siegfried from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to CHF when you buy.
Step 3
Search SFZN and buy
Find Siegfried by name or by its ticker, SFZN, and place your order.
Why invest in Siegfried from India
What Siegfried does
Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. It offers drug substances, including exclusive synthesis that manufactures custom APIs. Siegfried operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Siegfried stock from India?
Yes. Indian residents and NRIs can buy Siegfried (SFZN) shares directly through Paasa. Siegfried is listed on the SIX Swiss Exchange, in the Drug Manufacturers - Specialty & Generic industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell Siegfried shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the CHF/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.